Dyslipidemias  >>  evacetrapib (LY2484595)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evacetrapib (LY2484595) / Eli Lilly
NCT02260635: A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia

Terminated
3
54
Japan
Evacetrapib, LY2484595, Placebo
Eli Lilly and Company
Hypercholesterolemia
07/15
12/15
NCT02260648: A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

Hourglass Jan 2016 - Mar 2016 : From trial in combination with atorvastatin in Japanese patients
Terminated
3
149
Japan
Evacetrapib, LY2484595, Ezetimibe, Atorvastatin, Placebo
Eli Lilly and Company
Hypercholesterolemia
11/15
11/15

Download Options